These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

223 related items for PubMed ID: 7433154

  • 21. Plasma lipoproteins, apolipoproteins, and proteins concerned with lipid metabolism.
    Calvert GD, Abbey M.
    Adv Clin Chem; 1985; 24():217-98. PubMed ID: 3911751
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. [Surgical correction of hyperlipoproteinemia in patients with ischemic heart disease].
    Klimov AN, Lebedev LV, Sedletskiĭ IuI, Triufanov VF, Nagornev VA.
    Kardiologiia; 1984 Feb; 24(2):21-4. PubMed ID: 6585597
    [Abstract] [Full Text] [Related]

  • 24. Serum HDL-cholesterol, apo-A-I and apo-E levels in patients with abnormal coronary arteries.
    Tan MH, Weldon KL, Albers JJ, Cheung MC, Havel RJ, Vigne JL.
    Clin Invest Med; 1980 Feb; 3(3-4):225-32. PubMed ID: 6784991
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. [Current theories on the role of lipoproteins of different classes in the etiology of arteriosclerosis].
    Gasilin VS, Kurdanov KhA.
    Ter Arkh; 1981 Feb; 53(8):130-8. PubMed ID: 7027512
    [No Abstract] [Full Text] [Related]

  • 30. Reduction of high density lipoprotein cholesterol and apoliproprotein A-I concentrations by a lipid-lowering diet.
    Vessby B, Boberg J, Gustafsson IB, Karlström B, Lithell H, Ostlund-Linqvist AM.
    Atherosclerosis; 1980 Jan; 35(1):21-7. PubMed ID: 6768372
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. [Comparative analysis of incidence of main risk factors, behavior characteristics and work activity in ischemic heart disease with normolipemia and hyperlipoproteinemia type II and IV].
    Ganelina IE, Krivoruchenko IV, Kruchinina IA, Pritykina NIa, Chernigovskaia SV.
    Kardiologiia; 1979 Aug; 19(8):78-82. PubMed ID: 226766
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Plasma lipoproteins, lipid transport, and atherosclerosis: recent developments.
    Miller NE.
    J Clin Pathol; 1979 Jul; 32(7):639-50. PubMed ID: 227940
    [No Abstract] [Full Text] [Related]

  • 36. Lowering effect of fenofibrate (procetofene) on lipoproteins in different types of hyperlipoproteinemias.
    Canzler H, Bojanovski D.
    Artery; 1980 Jul; 8(2):171-8. PubMed ID: 7458684
    [Abstract] [Full Text] [Related]

  • 37. Serum lipoproteins during childhood: normal concentrations and primary hyperlipoproteinemias.
    Widhalm K.
    Bibl Nutr Dieta; 1982 Jul; (31):140-3. PubMed ID: 6985556
    [No Abstract] [Full Text] [Related]

  • 38. Plasma lipoprotein levels and the prevalence of hyperlipoproteinemia in a Canadian working population.
    Jones GJ, Hewitt D, Godin GJ, Breckenridge WC, Bird J, Mishkel MA, Steiner G, Little JA.
    Can Med Assoc J; 1980 Jan 12; 122(1):37-8, 40-6. PubMed ID: 7363194
    [Abstract] [Full Text] [Related]

  • 39. Serum lipoproteins, apolipoproteins and intravenous fat tolerance in young athletes.
    Ericsson M, Johnson O, Tollin C, Furberg B, Backman C, Angquist K.
    Scand J Rehabil Med; 1982 Jan 12; 14(4):209-12. PubMed ID: 7178868
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.